In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor

被引：0
|
作者：
Burrell, LM
Rockell, MD
Powell, J
Johnston, CI
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1999年 / 12卷 / 04期
关键词：
vasopeptidase inhibitors; omapatrilat; angiotensin; natriuretic peptides;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：119A / 119A
页数：1
相关论文
共 50 条
  • [1] In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a vasopeptidase inhibitor, BMS189921.
    Burrell, L
    Hubner, R
    Powell, J
    Johnston, C
    JOURNAL OF HYPERTENSION, 2000, 18 : S93 - S93
  • [2] In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat
    Hubner, RA
    Kubota, E
    Casley, DJ
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2001, 19 (05) : 941 - 946
  • [3] In vivo vasopeptidase inhibition: Simultaneous inhibition of neutral endopeptidase and angiotensin converting enzyme by BMS-189921
    Hubner, RA
    Paxton, D
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2000, 18 : S13 - S13
  • [4] Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo
    Bäcklund, T
    Palojoki, E
    Grönholm, T
    Eriksson, A
    Vuolteenaho, O
    Laine, M
    Tikkanen, I
    PHARMACOLOGICAL RESEARCH, 2001, 44 (05) : 411 - 418
  • [5] DUAL INHIBITOR OF ANGIOTENSIN-I-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE
    DAGE, RC
    MEHDI, S
    GIROUX, EL
    FRENCH, JF
    FLYNN, GA
    CIRCULATION, 1992, 86 (04) : 140 - 140
  • [6] Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes
    Anastasopoulos, F
    Leung, R
    Kladis, A
    James, GM
    Briscoe, TA
    Gorski, TP
    Campbell, DJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (03): : 799 - 805
  • [7] CHARACTERIZATION OF A DUAL INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE
    FRENCH, JF
    FLYNN, GA
    GIROUX, EL
    MEHDI, S
    ANDERSON, B
    BEACH, DC
    KOEHL, JR
    DAGE, RC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (01): : 180 - 186
  • [8] In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors
    Seymour, AA
    Asaad, MM
    AbboaOffei, BE
    Smith, PL
    Rogers, WL
    Dorso, CR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (05) : 672 - 678
  • [9] DUAL INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE IN RATS WITH HYPERTENSION
    FRENCH, JF
    ANDERSON, BA
    DOWNS, TR
    DAGE, RC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (01) : 107 - 113
  • [10] Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans
    Massien, C
    Azizi, M
    Guyene, TT
    Vesterqvist, O
    Mangold, B
    Ménard, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (04) : 448 - 459
12345